Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

前列腺癌医学前列腺癌症阉割肿瘤科内科学激素

作者

Silke Gillessen,Alberto Bossi,Ian D. Davis,Johann S. de Bono,Karim Fizazi,Nicholas D. James,Nicolas Mottet,Neal D. Shore,Eric J. Small,Matthew R. Smith,Christopher J. Sweeney,Bertrand Tombal,Emmanuel S. Antonarakis,Ana M. Aparicio,Andrew J. Armstrong,Gerhardt Attard,Tomasz M. Beer,Himisha Beltran,Anders Bjartell,Pierre Blanchard,Alberto Briganti,Robert G. Bristow,Muhammad Bulbul,Orazio Caffo,Daniel Castellano,Elena Castro,Heather H. Cheng,Kim N.,Simon Chowdhury,Caroline S. Clarke,Noel W. Clarke,Gedske Daugaard,Maria De Santis,Ignacio Durán,Ross Eeles,Eleni Efstathiou,Jason A. Efstathiou,Onyeanunam Ngozi Ekeke,Christopher P. Evans,Stefano Fanti,Felix Y. Feng,Valérie Fonteyne,Nicola Fossati,Mark Frydenberg,Dan George,Martin Gleave,Gwénaëlle Gravis,Susan Halabi,Daniel Heinrich,Ken Herrmann,Celestia Higano,Michael S. Hofman,Lisa G. Horvath,Maha Hussain,Barbara Alicja Jereczek‐Fossa,Robert J. Jones,Ravindran Kanesvaran,Pirkko‐Liisa Kellokumpu‐Lehtinen,Raja B. Khauli,Laurence Klotz,Gero Kramer,Raja Leibowitz,Christopher Logothetis,Brandon A. Mahal,Fernando Cotait Maluf,Joaquı́n Mateo,David Matheson,Niven Mehra,Axel S. Merseburger,Amee Morgans,Michael J. Morris,Hind Mrabti,Deborah Mukherji,Declan G. Murphy,Vedang Murthy,Paul L. Nguyen,William Oh,Piet Ost,Joe M. O’Sullivan,Anwar R. Padhani,Carmel Pezaro,Darren M.C. Poon,Colin C. Pritchard,Danny Rabah,Dana E. Rathkopf,Robert E. Reiter,Mark A. Rubin,Charles J. Ryan,Fred Saad,Juan Pablo Sade,Oliver Sartor,Howard I. Scher,Nima Sharifi,Iwona Skoneczna,Howard R. Soule,Daniel E. Spratt,Sandy Srinivas,Cora N. Sternberg,Thomas Steuber,Hiroyoshi Suzuki,Matthew R. Sydes,Mary‐Ellen Taplin,Derya Tilki,Levent Türkeri,Fabio Turco,Hiroji Uemura,Hirotsugu Uemura,Yüksel Ürün,Claire L. Vale,Inge M. van Oort,Neha Vapiwala,Jochen Walz,Kosj Yamoah,Dingwei Ye,Evan Y. Yu,A. Zapatero,Thomas Zilli,Aurelius Omlin

出处

期刊：European Journal of Cancer [Elsevier]
日期：2023-03-03 卷期号：185: 178-215 被引量：87

标识

DOI：10.1016/j.ejca.2023.02.018

摘要

Innovations in imaging and molecular characterisation together with novel treatment options have improved outcomes in advanced prostate cancer. However, we still lack high-level evidence in many areas relevant to making management decisions in daily clinical practise. The 2022 Advanced Prostate Cancer Consensus Conference (APCCC 2022) addressed some questions in these areas to supplement guidelines that mostly are based on level 1 evidence.

求助该文献

最长约 10秒，即可获得该文献文件

Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

今日热心研友